Phase 1Completed
Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions
A Relative Bioavailability Study of 80 mg Pravastatin Sodium Tablets Under Non-Fasting Conditions
- Sponsor
- Teva Pharmaceuticals USA (Industry)
- Enrollment
- 16 enrolled
- Conditions
- Healthy
- Interventions
- Pravastatin; Pravastatin
- Ages
- adults, older adults
- Registry
- NCT00829309
Full record on ClinicalTrials.gov
From the registry
This study compared the relative bioavailability (rate and extent of absorption) of Pravastatin Sodium Tablets 80 mg by Teva Pharmaceutical Industries, Ltd. with that of Pravachol® Tablets 80 mg by Bristol-Myers Squibb Company following a single oral dose (1 x 80 mg tablet)in healthy adult male subjects administered under non-fasting conditions.
Primary outcomes
- Cmax - Maximum Observed Concentration - Pravastatin in Plasma
- AUC0-inf - Area Under the Concentration-time Curve From Time Zero to Infinity (Extrapolated)
- AUC0-t - Area Under the Concentration-time Curve From Time Zero to Time of Last Non-zero Concentration (Per Participant)
History
Last registry update
Results first posted
Registered
Started
Primary completion